Logo image of BKYI

BIO-KEY INTERNATIONAL INC (BKYI) Stock Fundamental Analysis

NASDAQ:BKYI - Nasdaq - US09060C5076 - Common Stock - Currency: USD

1.35  -0.08 (-5.59%)

Fundamental Rating

1

BKYI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 286 industry peers in the Software industry. Both the profitability and financial health of BKYI have multiple concerns. BKYI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BKYI had negative earnings in the past year.
In the past year BKYI has reported a negative cash flow from operations.
BKYI had negative earnings in each of the past 5 years.
BKYI had a negative operating cash flow in each of the past 5 years.
BKYI Yearly Net Income VS EBIT VS OCF VS FCFBKYI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -142.02%, BKYI is not doing good in the industry: 93.19% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -6831.79%, BKYI is doing worse than 88.89% of the companies in the same industry.
Industry RankSector Rank
ROA -142.02%
ROE -6831.79%
ROIC N/A
ROA(3y)-107.41%
ROA(5y)-189.86%
ROE(3y)-352.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BKYI Yearly ROA, ROE, ROICBKYI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

BKYI has a Gross Margin of 14.78%. This is amonst the worse of the industry: BKYI underperforms 87.10% of its industry peers.
BKYI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for BKYI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.43%
GM growth 5YN/A
BKYI Yearly Profit, Operating, Gross MarginsBKYI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

More info and screens

1

2. Health

2.1 Basic Checks

BKYI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BKYI has been reduced compared to 1 year ago.
The number of shares outstanding for BKYI has been reduced compared to 5 years ago.
The debt/assets ratio for BKYI has been reduced compared to a year ago.
BKYI Yearly Shares OutstandingBKYI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
BKYI Yearly Total Debt VS Total AssetsBKYI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -31.58, we must say that BKYI is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -31.58, BKYI is doing worse than 96.06% of the companies in the same industry.
BKYI has a Debt/Equity ratio of 16.90. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 16.90, BKYI is doing worse than 88.53% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 16.9
Debt/FCF N/A
Altman-Z -31.58
ROIC/WACCN/A
WACC12.2%
BKYI Yearly LT Debt VS Equity VS FCFBKYI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

BKYI has a Current Ratio of 0.78. This is a bad value and indicates that BKYI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.78, BKYI is doing worse than 84.59% of the companies in the same industry.
BKYI has a Quick Ratio of 0.78. This is a bad value and indicates that BKYI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.71, BKYI is doing worse than 86.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.71
BKYI Yearly Current Assets VS Current LiabilitesBKYI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

BKYI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -344.95%.
Looking at the last year, BKYI shows a very negative growth in Revenue. The Revenue has decreased by -25.56% in the last year.
BKYI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.93% yearly.
EPS 1Y (TTM)-344.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.06%
Revenue 1Y (TTM)-25.56%
Revenue growth 3Y39.77%
Revenue growth 5Y13.93%
Sales Q2Q%18.03%

3.2 Future

The Earnings Per Share is expected to decrease by -33.91% on average over the next years. This is quite bad
BKYI is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.80% yearly.
EPS Next Y-113.79%
EPS Next 2Y-33.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-22.48%
Revenue Next 2Y-7.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BKYI Yearly Revenue VS EstimatesBKYI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BKYI Yearly EPS VS EstimatesBKYI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BKYI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BKYI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKYI Price Earnings VS Forward Price EarningsBKYI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKYI Per share dataBKYI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8 -10

4.3 Compensation for Growth

BKYI's earnings are expected to decrease with -33.91% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.91%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BKYI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BIO-KEY INTERNATIONAL INC

NASDAQ:BKYI (1/30/2025, 1:33:15 PM)

1.35

-0.08 (-5.59%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)N/A N/A
Inst Owners4.95%
Inst Owner Change0%
Ins Owners5.53%
Ins Owner Change2.72%
Market Cap4.23M
Analysts82.86
Price Target3.06 (126.67%)
Short Float %12.89%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-23.74%
Min EPS beat(2)-81.55%
Max EPS beat(2)34.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.6%
Min Revenue beat(2)-42.62%
Max Revenue beat(2)31.42%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)16.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)13.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.66
P/FCF N/A
P/OCF N/A
P/B 31.76
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.12
EYN/A
EPS(NY)-1.59
Fwd EYN/A
FCF(TTM)-1.26
FCFYN/A
OCF(TTM)-1.26
OCFYN/A
SpS2.04
BVpS0.04
TBVpS-0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -142.02%
ROE -6831.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.78%
FCFM N/A
ROA(3y)-107.41%
ROA(5y)-189.86%
ROE(3y)-352.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.43%
GM growth 5YN/A
F-Score3
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 16.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.05%
Cap/Sales 0.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.71
Altman-Z -31.58
F-Score3
WACC12.2%
ROIC/WACCN/A
Cap/Depr(3y)11.68%
Cap/Depr(5y)11.43%
Cap/Sales(3y)0.65%
Cap/Sales(5y)0.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-344.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.06%
EPS Next Y-113.79%
EPS Next 2Y-33.91%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-25.56%
Revenue growth 3Y39.77%
Revenue growth 5Y13.93%
Sales Q2Q%18.03%
Revenue Next Year-22.48%
Revenue Next 2Y-7.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y36.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.6%
OCF growth 3YN/A
OCF growth 5YN/A